People
-
Australia ‘boiling the frog’ in medicines policy
- Mon Apr 20
Australia is on a dangerous trajectory, says Roche MD Nic Horridge, who has a plan to reverse this trend and secure greater investment.
Read more -
Formidable trio nominate for MA Board
- Wed Apr 1
Three female leaders with strong experience across countries, companies, and sectors are the latest to announce they will nominate for the MA Board.
Read more -
Lorenz named as incoming GBMA CEO
- Wed Apr 1
Pharma industry professional Nikki Lorenz takes over as CEO of the industry association this month from long-term CEO Marnie Peterson.
Read more -
Leaders jump into MA Board race
- Mon Mar 30
With nominations opening tomorrow, the MA Board race is already underway as three more company heads reveal they will contest the four vacancies.
Read more -
Impossible is not an option for Lilly’s Manny Simons
- Mon Mar 30
For anything worth doing, impossible ‘just doesn’t enter the conversation’ says Simons, who is set to nominate for a seat on the MA Board.
Read more -
Another big pharma GM departs
- Wed Mar 25
Announcement from Medicines Australia regarding a Board election imminent as a fourth director leaves their company, and the Board.
Read more -
Bastas bounds up Australia’s Rich List
- Wed Mar 25
With greater personal wealth than James Packer, Dennis Bastas is officially Australian pharma’s biggest success story – and he’s just getting started.
Read more -
GSK boss will nominate for MA Board
- Mon Mar 23
Nominations are expected to open this week for four MA Board vacancies. GSK’s Andrew Thomas tells MedNews why he will run, and what his focus will be.
Read more